Discovery of an Oxybenzylglycine Based Peroxisome Proliferator Activated Receptor α Selective Agonist 2-((3-((2-(4-Chlorophenyl)-5-methyloxazol-4-yl)methoxy)benzyl)(methoxycarbonyl)amino)acetic Acid (BMS-687453)
Jun Li(Bristol-Myers Squibb (United States)), Joseph A. Tino(Institut des Maladies Métaboliques et Cardiovasculaires), Denise Grimm(Louisville Metabolic and Atherosclerosis Research Center), Lori Kunselman(Bristol-Myers Squibb (United States)), Yan Shi(Institut des Maladies Métaboliques et Cardiovasculaires), Bang‐Chi Chen(Bristol-Myers Squibb (United States)), Shiwei Tao(Bristol-Myers Squibb (Germany)), Shung Wu(Institut des Maladies Métaboliques et Cardiovasculaires), Peter T. W. Cheng(Bristol-Myers Squibb (United States)), Michael Cap, Carrie Xu, Michael A. Blanar(Bristol-Myers Squibb (United States)), Rongan Zhang(Bristol-Myers Squibb (United States)), Ngiap‐Kie Lim, Bowman Miao(Louisville Metabolic and Atherosclerosis Research Center), Andrés S. Hernández(Institut des Maladies Métaboliques et Cardiovasculaires), Pratik Devasthale(Institut des Maladies Métaboliques et Cardiovasculaires), Lawrence J. Kennedy(Bristol-Myers Squibb (United States)), Lisa Zhang(The University of Sydney), Denis E. Ryono(Institut des Maladies Métaboliques et Cardiovasculaires), Pathanjali Kadiyala(Louisville Metabolic and Atherosclerosis Research Center), Xiang‐Yang Ye(Hangzhou Normal University), Stanley R. Krystek(Collaborative Drug Discovery (United States)), Rebecca A. Smirk(Institut des Maladies Métaboliques et Cardiovasculaires), Robert Zahler(Institut des Maladies Métaboliques et Cardiovasculaires), Debra Search(Louisville Metabolic and Atherosclerosis Research Center), J.K. Muckelbauer(Institute of Crystallography), Ranjan Mukherjee(Ligand Pharmaceuticals (United States)), Vinayak Hosagrahara, Hossain Monshizadegan(Louisville Metabolic and Atherosclerosis Research Center), Kenneth T. Locke(Medicines Evaluation Unit), Ying Wang(Qiqihar Medical University), Wei Wang(Binzhou Medical University), Hao Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College), Yixin Li(Baylor College of Medicine), Huiping Zhang(Huazhong University of Science and Technology), Stephanie Chen(Rutgers, The State University of New Jersey), Litao Zhang(Tianjin University of Traditional Chinese Medicine), Sean Chen(Rutgers, The State University of New Jersey), Rai Ajit K. Srivastava(Drexel University), Kevin O’Malley(Medicines Evaluation Unit), ChiehYing Y. Chang(Institute of Crystallography), Zhi Lai(Institut des Maladies Métaboliques et Cardiovasculaires), Daniel S. Meyers(Louisville Metabolic and Atherosclerosis Research Center), Thomas Harrity(Bristol-Myers Squibb (United States)), Scott A. Bolton(Institut des Maladies Métaboliques et Cardiovasculaires), Yongmi An(Protein Express (United States))
Cited by 41
Related Papers
A photoreceptor cell-specific ATP-binding transporter gene (ABCR) is mutated in recessive Starqardt macular dystrophy
|Nature Genetics|1997|1.4k
Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties
|Cell|1992|840
RAGE potentiates Aβ‐induced perturbation of neuronal function in transgenic mice
|The EMBO Journal|2004|327
Genotype/Phenotype Analysis of a Photoreceptor-Specific ATP-Binding Cassette Transporter Gene, ABCR, in Stargardt Disease
|The American Journal of Human Genetics|1999|302